ConductScience.org, home

Paper973958

A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.

Branch RA and 2 others. Br J Clin Pharmacol, 1976. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. Papers, record 973958. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/973958

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
5.45
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Branch RAR A
2James JJ
3Read AEA E

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver DiseasesMajor topic
PropranololMajor topic
Adult
Aged
Chronic Disease
Female
Glomerular Filtration Rate
Hepatitis
Humans
Liver Cirrhosis
Liver Function Tests
Male
Middle Aged
Protein Binding

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114412753Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.J Clin Invest1959https://conductscience.org/library/papers/14412753PubMed
25410893Plasma propranolol levels in adults with observations in four children.Clin Pharmacol Ther1970https://conductscience.org/library/papers/5410893PubMed
313809697Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction.J Clin Invest1960https://conductscience.org/library/papers/13809697PubMed
413689739The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin Sci1961https://conductscience.org/library/papers/13689739PubMed
65454254Pharmacodynamics of carbenicillin in hepatic and renal failure.Ann Intern Med1970https://conductscience.org/library/papers/5454254PubMed
74764426Clearance concepts in pharmacokinetics.J Pharmacokinet Biopharm1973https://conductscience.org/library/papers/4764426PubMed
85040665Metabolism of amylobarbitone in patients with chronic liver disease.Br J Pharmacol1972https://conductscience.org/library/papers/5040665PubMed
94729926Determinants of serum antipyrine half-lives in patients with liver disease.Gut1973https://conductscience.org/library/papers/4729926PubMed
104172137Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.Lancet1968https://conductscience.org/library/papers/4172137PubMed
115652110Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.J Pharm Sci1968https://conductscience.org/library/papers/5652110PubMed
124198771The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4198771PubMed
134629296Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate.Am Heart J1973https://conductscience.org/library/papers/4629296PubMed
144723256Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723256PubMed
154655684Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.Eur J Clin Pharmacol1972https://conductscience.org/library/papers/4655684PubMed
165060669Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.Gut1972https://conductscience.org/library/papers/5060669PubMed
1714192527ASSESSMENT OF PORTAL AND HEPATIC HEMODYNAMICS AFTER SIDE-TO-SIDE PORTACAVAL SHUNT IN PATIENTS WITH CIRRHOSIS.J Clin Invest1964https://conductscience.org/library/papers/14192527PubMed

Download CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42787343Multi-species assessment of propranolol pharmacokinetics via minimal and whole-body PBPK modeling.Front Pharmacol2026https://conductscience.org/library/papers/42787343PubMed
27519334Disposition, Elimination and Haemodynamic Effects of Gallopamil in Patients with Fatty Liver Disease.Clin Drug Investig1995https://conductscience.org/library/papers/27519334PubMed
24906133A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.PLoS One2014https://conductscience.org/library/papers/24906133PubMed
9820880Effect of hepatic insufficiency on pharmacokinetics and drug dosing.Pharm World Sci1998https://conductscience.org/library/papers/9820880PubMed
7333059Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.Clin Pharmacokinet1981https://conductscience.org/library/papers/7333059PubMed
7249488Altered plasma protein binding of drugs in thyroid disease.Clin Pharmacokinet1981https://conductscience.org/library/papers/7249488PubMed
7238566Development of a model for integrated pharmacokinetic and pharmacodynamic studies of intravenous anaesthetic agents: applications to minaxolone.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7238566PubMed
7213505Pethidine clearance during continuous intravenous infusions in postoperative patients.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7213505PubMed
7014827A standard approach to compiling clinical pharmacokinetic data.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7014827PubMed
6360815Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.Gut1984https://conductscience.org/library/papers/6360815PubMed
6156048Disease-induced changes in the plasma binding of basic drugs.Clin Pharmacokinet1980https://conductscience.org/library/papers/6156048PubMed
3965362Pharmacology of propranolol in patients with cirrhosis and portal hypertension.Gut1985https://conductscience.org/library/papers/3965362PubMed
3689632A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3689632PubMed
3663453Propranolol disposition in patients with hepatosplenic schistosomiasis.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3663453PubMed
3296480Pharmacokinetics and pharmacodynamics in critically ill patients.World J Surg1987https://conductscience.org/library/papers/3296480PubMed
3243323Influence of obesity on sulfonamide disposition in Zucker rats.Eur J Drug Metab Pharmacokinet1988https://conductscience.org/library/papers/3243323PubMed
2569324Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2569324PubMed
2203581Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).Clin Pharmacokinet1990https://conductscience.org/library/papers/2203581PubMed
1458763Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.Clin Pharmacokinet1992https://conductscience.org/library/papers/1458763PubMed
1017718Intravenous administration of diazepam in patients with chronic liver disease.Gut1976https://conductscience.org/library/papers/1017718PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/973958

GET https://conductscience.org/api/papers/v1/973958/cited_by?page=2